Liquidity Services Announces Retirement of Patrick W. Gross

Liquidity Services Announces Retirement of Patrick W. Gross

Beatriz Infante Elected as New Lead Independent Director......

OceanPal Inc. Announces Appointment of Chief Executive

OceanPal Inc. Announces Appointment of Chief Executive

ATHENS, Greece, Feb. 02, 2023 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of......

Hub Group, Inc. Reports Fourth Quarter and Full Year 2022

Hub Group, Inc. Reports Fourth Quarter and Full Year 2022

Highlights: Diluted earnings per share (EPS) of $2.42 for the quarter, and $10.64 for the full year which is growth of 110%Full year revenue of $5.3......

Amerant Mortgage Grows its National Footprint with the

Amerant Mortgage Grows its National Footprint with the

Coral Gables, FL, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Amerant Mortgage, LLC, a subsidiary of Amerant Bank, the largest community bank headquartered in......

BiondVax Presenting at BIO CEO & Investor Conference

BiondVax Presenting at BIO CEO & Investor Conference

JERUSALEM, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on......

Silo Pharma Announces Expansion of Intellectual Property

Silo Pharma Announces Expansion of Intellectual Property

Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and Prevention of Stress-Induced Affective Disorders......

Surface Oncology to Participate in the 2023 Guggenheim

Surface Oncology to Participate in the 2023 Guggenheim

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......

Reneo Pharmaceuticals to Participate in SVB Securities

Reneo Pharmaceuticals to Participate in SVB Securities

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the......

Revolution Medicines to Participate in Upcoming Investor

Revolution Medicines to Participate in Upcoming Investor

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted......

Aurora Mobile Wins 2022 Excellent Digital Service Provider

Aurora Mobile Wins 2022 Excellent Digital Service Provider

SHENZHEN, China, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer......

  • 1
  • ...
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • menu
    menu